| C07051 |
Indinavir |
(P) unclassified |
| D00059 |
Levodopa (JP18/USP/INN); Dopar (TN) |
(P) unclassified |
| D00079 |
Dinoprostone (JAN/USP/INN); Cervidil (TN); Prepidil (TN); Prostin E2 (TN) |
(P) unclassified |
| D00081 |
Dinoprost (JP18/USAN/INN); Prosmon (TN) |
(P) unclassified |
| D00106 |
Epoprostenol (USAN/INN); Prostaglandin I2; Prostacyclin; Epoprostenol (TN) |
(P) unclassified |
| D00107 |
Tacrolimus (USP/INN); Tacrolimus hydrate (JP18); Prograf (TN); Protopic (TN) |
(CI) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00118 |
Naproxen (JP18/USP/INN); Naprosyn (TN) |
(P) unclassified |
| D00136 |
Haloperidol (JP18/USP/INN); Haldol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00151 |
Mefenamic acid (JP18/USP/INN); Ponstel (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D00180 |
Alprostadil (JP18/USP/INN); Prostin VR pediatric (TN); Caverject (TN); Edex (TN); Muse (TN) |
(P) unclassified |
| D00184 |
Cyclosporine (USP); Ciclosporin (JP18); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
| D00218 |
Acetazolamide (JP18/USP/INN); Diamox (TN) |
(P) unclassified |
| D00228 |
Amoxapine (JP18/USP/INN); Asendin (TN) |
(P) unclassified |
| D00241 |
Baclofen (JP18/USP/INN); Kemstro (TN); Lioresal (TN) |
(P) unclassified |
| D00253 |
Carbidopa hydrate and levodopa; Parcopa (TN); Sinemet (TN) |
(P) unclassified |
| D00283 |
Clozapine (JAN/USP/INN); Clozaril (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00292 |
Dexamethasone (JP18/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00294 |
Diazoxide (JAN/USP/INN); Hyperstat (TN); Proglycem (TN) |
(P) unclassified |
| D00296 |
Didanosine (JAN/USP/INN); Videx (TN) |
(P) unclassified |
| D00298 |
Digoxin (JP18/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00302 |
Dipyridamole (JP18/USP/INN); Persantine (TN) |
(P) unclassified |
| D00304 |
Divalproex sodium (USP); Valproate semisodium (INN); Depakote (TN) |
(P) unclassified |
| D00319 |
Felodipine (JP18/USP/INN); Plendil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00322 |
Fluconazole (JP18/USP/INN); Diflucan (TN) |
(P) CYP inhibition: CYP2C9 CYP3A4 |
| D00331 |
Furosemide (JP18/USP/INN); Frusemide; Lasix (TN) |
(P) unclassified |
| D00336 |
Glyburide (USP); Glibenclamide (JP18/INN); Diabeta (TN); Glynase (TN); Micronase (TN) |
(CI) Enzyme: CYP2C9 CYP3A4 / CYP induction: CYP2C9 CYP3A4 |
| D00346 |
Isoniazid (JP18/USP/INN); Laniazid (TN) |
(P) unclassified |
| D00349 |
Isradipine (USP/INN); Dynacirc (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00351 |
Ketoconazole (JP18/USP); Nizoral (TN); Xolegel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00353 |
Lamivudine (JAN/USP/INN); Epivir (TN) |
(P) unclassified |
| D00356 |
Latanoprost (JAN/USP/INN); Xalatan (TN) |
(P) unclassified |
| D00359 |
Lovastatin (USP/INN); MK-803; ML-530B; Mevacor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00382 |
Torsemide (USP); Torasemide (JAN/INN); Demadex (TN); Luprac (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D00383 |
Trandolapril (JAN/USP/INN); Mavik (TN) |
(P) unclassified |
| D00387 |
Triazolam (JP18/USP/INN); Halcion (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00399 |
Valproic acid (USP); Depakene (TN) |
(P) unclassified |
| D00405 |
Methyldopa (USP); Methyldopa hydrate (JP18); Aldomet (TN) |
(P) unclassified |
| D00412 |
Zalcitabine (JAN/USP/INN); Hivid (TN) |
(P) unclassified |
| D00413 |
Zidovudine (JP18/USP/INN); Azidothymidine; Retrovir (TN) |
(P) unclassified |
| D00419 |
Misoprostol (JAN/USP/INN); Cytotec (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00426 |
Risperidone (JP18/USP/INN); Risperdal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00427 |
Ritonavir (JAN/USP/INN); Norvir (TN) |
(P) CYP induction: CYP2C9 |
| D00429 |
Saquinavir (JAN/USP/INN); Fortovase (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00432 |
Nadolol (JP18/USP/INN); Corgard (TN) |
(P) unclassified |
| D00434 |
Simvastatin (JP18/USP/INN); MK-733; Zocor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00437 |
Nifedipine (JP18/USP/INN); Adalat (TN); Afeditab CR (TN); Procardia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00438 |
Nimodipine (USP/INN); Nimotop (TN); Nymalize (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00443 |
Spironolactone (JP18/USP/INN); Aldactone (TN) |
(P) unclassified |
| D00445 |
Stavudine (USAN/INN); Sanilvudine (JAN); Zerit (TN) |
(P) unclassified |
| D00458 |
Quetiapine fumarate (JP18/USP); Seroquel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00479 |
Prochlorperazine maleate (JP18/USP); Compazine (TN) |
(P) unclassified |
| D00480 |
Promethazine hydrochloride (JP18/USP); Phenergan (TN); Promethegan (TN) |
(P) unclassified |
| D00503 |
Perphenazine (JP18/USP/INN); Trilafon (TN) |
(P) unclassified |
| D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) CYP induction: CYP2C9 |
| D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D00515 |
Nitroglycerin (JP18/USP); Glyceryl trinitrate; Minitran (TN); Nitro-bid (TN); Nitro-dur (TN); Nitromist (TN); Transderm-nitro (TN) |
(P) unclassified |
| D00537 |
Topiramate (JAN/USP/INN); Topamax (TN); Trokendi xr (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00538 |
Zonisamide (JP18/USP/INN); Excegran (TN) |
(P) unclassified |
| D00539 |
Ethosuximide (JP18/USP/INN); Zarontin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00547 |
Sevoflurane (JP18/USAN/INN); Ultane (TN) |
(P) unclassified |
| D00549 |
Propofol (JAN/USP/INN); Diprivan (TN) |
(P) unclassified |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00553 |
Prilocaine (USP/INN); Propitocaine (JAN) |
(P) unclassified |
| D00554 |
Ethinyl estradiol (USP); Ethinylestradiol (JP18/INN); Estinyl (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00563 |
Mirtazapine (JAN/USP/INN); Remeron (TN); Reflex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D00599 |
Carteolol hydrochloride (JP18/USP); Cartrol (TN); Ocupress (TN) |
(P) unclassified |
| D00606 |
Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00608 |
Doxazosin mesylate (USP); Doxazosin mesilate (JP18); Cardura (TN) |
(P) unclassified |
| D00609 |
Prazosin hydrochloride (JP18/USP); Minipress (TN) |
(P) unclassified |
| D00615 |
Amlodipine besylate (USP); Amlodipine besilate (JP18); Norvasc (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00616 |
Diltiazem hydrochloride (JP18/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00617 |
Nicardipine hydrochloride (JP18/USAN); Cardene (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00618 |
Nisoldipine (JAN/USAN/INN); Sular (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP18/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00629 |
Nitrendipine (JP18/USAN/INN); Baypress (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00631 |
Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN); Vascor (TN) |
(P) Enzyme: CYP2C9 CYP3A4 / CYP induction: CYP2C9 CYP3A4 |
| D00634 |
Bisoprolol fumarate (JP18/USP); Zebeta (TN) |
(P) unclassified |
| D00636 |
Amiodarone hydrochloride (JP18/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00658 |
Trichlormethiazide (JP18/USP/INN); Naqua (TN) |
(P) unclassified |
| D00678 |
Ondansetron hydrochloride hydrate (JAN/USP); Ondansetron hydrochloride; Zofran (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00682 |
Carboprost tromethamine (USP); Hemabate (TN) |
(P) unclassified |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) CYP induction: CYP2C9 |
| D00710 |
Valproate sodium (USAN); Sodium valproate (JP18); Depakene (TN); Selenica (TN) |
(P) unclassified |
| D00713 |
Thiamylal sodium (JP18); Surital (TN) |
(P) unclassified |
| D00714 |
Thiopental sodium (JP18/USP/INN); Pentothal (TN) |
(P) unclassified |
| D00762 |
Metyrosine (USP); Metirosine (JAN/INN); Demser (TN) |
(P) unclassified |
| D00776 |
Tizanidine hydrochloride (JP18/USP); Zanaflex (TN) |
(P) unclassified |
| D00789 |
Chlorpromazine hydrochloride (JP18/USP); Sonazine (TN) |
(P) unclassified |
| D00793 |
Fluphenazine decanoate (JAN/USP); Prolixin decanoate (TN) |
(P) unclassified |
| D00809 |
Amitriptyline hydrochloride (JP18/USP); Elavil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00811 |
Clomipramine hydrochloride (JP18/USP); Anafranil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00815 |
Imipramine hydrochloride (JP18/USP); Tofranil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00820 |
Trazodone hydrochloride (JAN/USP); Desyrel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00831 |
Mefloquine hydrochloride (JP18/USP); Lariam (TN) |
(P) unclassified |
| D00836 |
Buprenorphine hydrochloride (JP18/USP); Buprenex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00887 |
Atorvastatin calcium anhydorous; Lipitor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00889 |
Cerivastatin sodium (JAN/USAN); Baycol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00891 |
Abacavir sulfate (JAN/USP); Ziagen (TN) |
(P) unclassified |
| D00892 |
Fluvastatin sodium (JAN/USP); Lescol (TN) |
(P) Enzyme: CYP2C9 CYP3A4 / CYP inhibition: CYP2C9 / CYP induction: CYP2C9 CYP3A4 |
| D00893 |
Pravastatin sodium (JP18/USP); CS-514; Pravachol (TN) |
(P) unclassified |
| D00894 |
Amprenavir (JAN/USAN/INN); Agenerase (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00895 |
Delavirdine mesylate (USAN); Delavirdine mesilate (JAN); Rescriptor (TN) |
(P) unclassified |
| D00896 |
Efavirenz (JAN/USP/INN); Sustiva (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00897 |
Indinavir sulfate (USP); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00899 |
Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00904 |
Diclofenac sodium (JP18/USP); Solaraze (TN); Voltaren (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D00950 |
Levonorgestrel (JAN/USP/INN); Mirena (TN); Norplant (TN); Skyla (TN) |
(P) unclassified |
| D00961 |
Bicalutamide (JP18/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00964 |
Letrozole (JAN/USP/INN); Femara (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00969 |
Meloxicam (JAN/USP/INN); Mobic (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D00975 |
Dexamethasone sodium phosphate (JAN/USP); Dalalone (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00987 |
Cabergoline (JP18/USP/INN); Cabaser (TN); Dostinex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01024 |
Tamsulosin hydrochloride (JP18/USP); Flomax (TN); Harnal (TN) |
(P) unclassified |
| D01055 |
Emivirine (USAN/INN); Coactinon (TN) |
(P) unclassified |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
| D01104 |
Barnidipine hydrochloride (JAN); Hypoca (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01107 |
Milnacipran hydrochloride (JAN/USAN); Savella (TN); Toledomin (TN) |
(P) unclassified |
| D01115 |
Eplerenone (JP18/USAN/INN); Inspra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01145 |
Azelnidipine (JP18/INN); Calblock (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01160 |
Saquinavir mesylate (USP); Saquinavir mesilate (JAN); Invirase (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01164 |
Aripiprazole (JAN/USP/INN); Abilify (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01173 |
Cilnidipine (JP18/INN); Atelec (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01176 |
Blonanserin (JAN/INN); AD 5423 |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01179 |
Duloxetine hydrochloride (JAN/USP); Cymbalta (TN); Yentreve (TN) |
(P) unclassified |
| D01188 |
Pimilprost (JAN/INN) |
(P) unclassified |
| D01196 |
Acetazolamide sodium (JAN); Diamox (TN) |
(P) unclassified |
| D01199 |
Emtricitabine (JAN/USAN/INN); Emtriva (TN) |
(P) unclassified |
| D01213 |
Tolvaptan (JAN/USAN/INN); Samsca (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01240 |
Deslanoside (JP18/USP/INN); Cedilanid-d (TN) |
(P) unclassified |
| D01243 |
Prilocaine hydrochloride (USP); Propitocaine hydrochloride (JAN); Citanest (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D01302 |
Hydralazine hydrochloride (JP18/USP); Apresoline (TN) |
(P) unclassified |
| D01303 |
Flunarizine hydrochloride (JAN/USAN) |
(P) unclassified |
| D01321 |
Zotepine (JAN/INN); Setous (TN) |
(P) unclassified |
| D01323 |
Azosemide (JP18/USAN/INN); Diart (TN) |
(P) unclassified |
| D01333 |
Urapidil (JP18/INN); Ebrantil (TN) |
(P) unclassified |
| D01337 |
Epoprostenol sodium (JAN/USAN); Flolan (TN); Veletri (TN) |
(P) unclassified |
| D01352 |
Dinoprost tromethamine (JAN/USP); Prostin F2 alpha (TN) |
(P) unclassified |
| D01358 |
Mianserin hydrochloride (JAN/USAN); Tetramide (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01372 |
Zopiclone (JP18/INN); Amoban (TN); Zopiclone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01399 |
Fentanyl citrate (JP18/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01418 |
Tamibarotene (JAN/USAN/INN); Am 80; Amnoid (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01425 |
Lopinavir (JAN/USP/INN) |
(P) unclassified |
| D01429 |
Fosfluconazole (JAN/INN); Prodif (TN) |
(P) CYP inhibition: CYP2C9 CYP3A4 |
| D01452 |
Isopropyl unoprostone (JAN); Unoprostone isopropyl; Rescula (TN) |
(P) unclassified |
| D01469 |
Amosulalol hydrochloride (JP18); Lowgan (TN) |
(P) unclassified |
| D01485 |
Propericiazine (JAN); Periciazine; Neuleptil (TN) |
(P) unclassified |
| D01520 |
Levomepromazine hydrochloride (JAN/USAN); Nozinan (TN) |
(P) unclassified |
| D01546 |
Dothiepin hydrochloride (USAN); Dosulepin hydrochloride (JAN); Dosulepin (TN) |
(P) unclassified |
| D01549 |
Imidapril hydrochloride (JP18); Tanatril (TN) |
(P) unclassified |
| D01551 |
Beraprost sodium (JP18/USAN); Procylin (TN) |
(P) unclassified |
| D01553 |
Manidipine hydrochloride (JP18); Manidipine dihydrochloride; Calslot (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01562 |
Aranidipine (JAN/INN); Sapresta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01578 |
Pranoprofen (JP18/INN); Elicapric (TN) |
(P) unclassified |
| D01604 |
Efonidipine hydrochloride ethanolate (JAN); Efonidipine hydrochloride ethanol; Efonidipine hydrochloride; NZ 105 ethanolate; Landel (TN) |
(P) unclassified |
| D01656 |
Brovincamine fumarate (JAN); Sabromin (TN) |
(P) unclassified |
| D01674 |
Naftopidil (JP18/INN); Flivas (TN) |
(P) unclassified |
| D01691 |
Nipradilol (JAN/INN); Hypadil (TN) |
(P) unclassified |
| D01709 |
Loxoprofen sodium hydrate (JP18); Lorfenamin (TN); Loxonin (TN) |
(P) unclassified |
| D01741 |
Celiprolol hydrochloride (JAN/USAN); Selectol (TN) |
(P) unclassified |
| D01744 |
Brotizolam (JP18/USAN/INN); Lendormin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01849 |
Lercanidipine hydrochloride (JAN/USAN); Cardiovasc (TN) |
(P) unclassified |
| D01862 |
Pitavastatin calcium (JAN); NK 104; Livalo (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D01869 |
Ornoprostil (JAN/INN); Ronok (TN) |
(P) unclassified |
| D01877 |
Mefruside (JP18/USAN/INN); Baycaron (TN) |
(P) unclassified |
| D01887 |
Bunazosin hydrochloride (JP18); Detantol (TN) |
(P) unclassified |
| D01891 |
Enprostil (JAN/USAN/INN); Camleed (TN) |
(P) unclassified |
| D01895 |
Tripamide (JAN/USAN/INN); Normonal (TN) |
(P) unclassified |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01902 |
Fonazine mesylate (USAN); Dimetotiazine mesilate (JAN); Banistyl (TN) |
(P) unclassified |
| D01908 |
Nilvadipine (JP18/USAN/INN); Nivadil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01915 |
Rosuvastatin calcium (JP18/USP); ZD 4522; Crestor (TN) |
(P) unclassified |
| D01933 |
Vatanidipine hydrochloride (JAN); AE 0047; Calbren (TN) |
(P) unclassified |
| D01943 |
Canrenoate potassium (USAN); Potassium canrenoate (JP18); Soldactone (TN) |
(P) unclassified |
| D01964 |
Travoprost (JAN/USP/INN); Travatan (TN) |
(P) unclassified |
| D01965 |
Silodosin (JP18/INN); KMD 3213; Rapaflo (TN); Urief (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01969 |
Gallopamil hydrochloride (JAN) |
(P) unclassified |
| D01977 |
Gefitinib (JP18/USAN/INN); Iressa (TN) |
(P) unclassified |
| D01982 |
Tenofovir disoproxil fumarate (JAN/USAN); Viread (TN) |
(P) unclassified |
| D02002 |
Isoniazid sodium methanesulfonate hydrate (JAN); Isoniazid sodium methanesulfonate monohydrate; Isoniazid sodium methanesulfonate; IHMS; Neoiscotin (TN) |
(P) unclassified |
| D02008 |
Tadalafil (JAN/USP/INN); Adcirca (TN); Cialis (TN); Zalutia (TN) |
(CI,P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02022 |
Prochlorperazine mesilate (JAN); Prochlorperazine dimethanesulfonate; Novamin (TN) |
(P) unclassified |
| D02034 |
Setiptiline maleate (JAN); Tecipul (TN) |
(P) unclassified |
| D02037 |
Perphenazine maleate (JP18); PZC (TN) |
(P) unclassified |
| D02045 |
Benidipine hydrochloride (JP18); KW 3049; Coniel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02048 |
Clinprost (JAN/INN); TEI 9090; Arteron (TN) |
(P) unclassified |
| D02073 |
Gemeprost (JAN/USAN/INN); Preglandin (TN) |
(P) unclassified |
| D02076 |
Brimonidine tartrate (JAN/USAN); Alphagan (TN) |
(P) unclassified |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D02135 |
Levodopa and benserazide hydrochloride; Madopar (TN) |
(P) unclassified |
| D02163 |
Fluphenazine maleate (JAN); Flumezin (TN) |
(P) unclassified |
| D02229 |
Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02245 |
Trimeprazine tartrate (USP); Alimemazine tartrate (JP18); Alimezine (TN) |
(P) unclassified |
| D02248 |
Levomepromazine maleate (JP18/USAN); Hirnamin (TN) |
(P) unclassified |
| D02258 |
Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP18); Atorvastatin calcium trihydrate; Atorvaliq (TN); Lipitor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02297 |
Emtricitabine and tenofovir disoproxil; Truvada (TN) |
(P) unclassified |
| D02342 |
Bisoprolol (JAN/USAN/INN) |
(P) unclassified |
| D02343 |
Carboprost (USAN/INN) |
(P) unclassified |
| D02356 |
Verapamil (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) unclassified |
| D02408 |
Trimipramine maleate (JAN/USP); Surmontil (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02497 |
Fosamprenavir (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02498 |
Lopinavir and ritonavir; Kaletra (TN) |
(P) unclassified |
| D02499 |
Enfuvirtide (USAN/INN); Fuzeon (TN) |
(P) unclassified |
| D02537 |
Dronedarone (INN) |
(P) unclassified |
| D02540 |
Garenoxacin mesylate (USAN); Garenoxacin mesilate hydrate (JAN) |
(P) unclassified |
| D02587 |
Metildigoxin (JP18); Lanirapid (TN) |
(P) unclassified |
| D02624 |
Eszopiclone (JAN/USP/INN); Estorra (TN); Lunesta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02629 |
Fluspirilene (USAN/INN); Imap (TN) |
(P) unclassified |
| D02630 |
Penfluridol (USAN/INN); Semap (TN) |
(P) unclassified |
| D02633 |
Lomerizine hydrochloride (JAN); Terranas (TN) |
(P) unclassified |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
| D02705 |
Alprostadil alfadex (JP18); Tandetron (TN); Caverject (TN) |
(P) unclassified |
| D02719 |
Rosaprostol (INN) |
(P) unclassified |
| D02720 |
Beraprost (USAN) |
(P) unclassified |
| D02721 |
Iloprost (USAN/INN); Ventavis (TN) |
(P) unclassified |
| D02722 |
Limaprost (INN) |
(P) unclassified |
| D02723 |
Ecraprost (USAN/INN) |
(P) unclassified |
| D02724 |
Bimatoprost (JAN/USAN/INN); Lumigan (TN); Latisse (TN) |
(P) unclassified |
| D02725 |
Sulprostone (USAN/INN) |
(P) unclassified |
| D02731 |
Vardenafil dihydrochoride (USAN); Levitra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02732 |
Pranlukast hydrate (JP18); Onon (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02734 |
Abacavir succinate (USAN) |
(P) unclassified |
| D02802 |
Alemtuzumab (USAN/INN); Alemtuzumab (genetical recombination) (JAN); Campath (TN); Lemtrada (TN) |
(P) unclassified |
| D02860 |
Limaprost alfadex (JP18); Opalmon (TN) |
(P) unclassified |
| D02861 |
Indinavir sulfate ethanolate (JAN); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02867 |
Fosamprenavir calcium hydrate (JAN); Lexiva (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02890 |
Amdoxovir (USAN/INN) |
(P) unclassified |
| D02914 |
Amlodipine maleate (USAN); Amvaz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 CYP2C9 |
| D02994 |
Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN); Rituximab-abbs; Rituximab-pvvr; Rituximab-arrx; Rituxan (TN); Riabni (TN); Truximab (TN) |
(P) unclassified |
| D02995 |
Asenapine maleate (JAN/USAN); Saphris (TN) |
(P) unclassified |
| D03001 |
Atevirdine mesylate (USAN) |
(P) unclassified |
| D03067 |
Belfosdil (USAN/INN) |
(P) unclassified |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03150 |
Bortezomib (JAN/USAN/INN); Velcade (TN) |
(P) unclassified |
| D03187 |
Butaprost (USAN/INN) |
(P) unclassified |
| D03217 |
Avanafil (USAN/INN); Stendra (TN); Spedra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03253 |
Brecanavir (USAN) |
(P) unclassified |
| D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03269 |
Dinoprostone betadex (JAN); Prostarmon E (TN) |
(P) unclassified |
| D03290 |
Promethazine methylenedisalicylate (JAN); Pyrethia (TN) |
(P) unclassified |
| D03371 |
Capravirine (USAN/INN) |
(P) unclassified |
| D03399 |
Carboprost methyl (USAN) |
(P) unclassified |
| D03522 |
Ciprostene calcium (USAN) |
(P) unclassified |
| D03536 |
Clentiazem maleate (JAN/USAN) |
(P) unclassified |
| D03601 |
Crilvastatin (USAN/INN) |
(P) unclassified |
| D03643 |
Dalvastatin (USAN/INN) |
(P) unclassified |
| D03655 |
Darodipine (USAN/INN) |
(P) unclassified |
| D03656 |
Darunavir (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03657 |
Dasantafil (USAN/INN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
| D03799 |
Dienogest (JAN/USAN/INN); Endometrion (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03816 |
Tenivastatin calcium (USAN) |
(P) unclassified |
| D03830 |
Diltiazem malate (USAN); Tiamate (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03833 |
Indinavir (USAN); Indinavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03835 |
Fosamprenavir calcium (USAN); Lexiva (TN); Telzir (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03837 |
Fosamprenavir sodium (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03839 |
Droxinavir hydrochloride (USAN) |
(P) unclassified |
| D03840 |
Palinavir (USAN/INN) |
(P) unclassified |
| D03842 |
Telinavir (USAN/INN) |
(P) unclassified |
| D03843 |
Tipranavir disodium (USAN) |
(P) unclassified |
| D03914 |
Dronedarone hydrochloride (USP); Multaq (TN) |
(P) unclassified |
| D03981 |
Elvucitabine (USAN/INN) |
(P) unclassified |
| D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04034 |
Chlorpromazine phenolphthalinate (JAN); Wintermin (TN) |
(P) unclassified |
| D04038 |
Perphenazine fendizoate (JAN); PZC (TN) |
(P) unclassified |
| D04046 |
Salicylamide, acetaminophen, anhydrous caffeine and promethazine methylenedisalicylate; PL (TN) |
(P) unclassified |
| D04059 |
Mepenzolate bromide and phenobarbital; Trancolon P (TN) |
(P) unclassified |
| D04104 |
Etonogestrel (USAN/INN); Implanon (TN); Nexplanon (TN) |
(P) unclassified |
| D04112 |
Etravirine (JAN/USAN/INN); Intelence (TN) |
(P) Enzyme: CYP2C9 CYP3A4 / CYP inhibition: CYP2C9 / CYP induction: CYP2C9 CYP3A4 |
| D04193 |
Flordipine (USAN/INN) |
(P) unclassified |
| D04260 |
Fostedil (USAN/INN) |
(P) unclassified |
| D04460 |
Ethinylestradiol and ethynodiol diacetate; Edulen (TN); Zovia (TN) |
(P) unclassified |
| D04463 |
Norgestrel and ethinylestradiol tablets (JP18); Low-ogestrel (TN); Planovar (TN) |
(P) Enzyme: CYP2C9 CYP3A4 / CYP induction: CYP2C9 CYP3A4 |
| D04482 |
Ethinylestradiol and levonorgestrel; Ange (TN); Levora (TN); Lo/ovral (TN); Seasonique (TN); Triphasil-21 (TN); Trivora (TN) |
(P) unclassified |
| D04483 |
Ethinylestradiol and norethisterone; Norethindrone and ethinyl estradiol; Synphase T28 (TN) |
(P) unclassified |
| D04484 |
Desogestrel and ethinylestradiol; Marvelon21 (TN); Ortho-cept (TN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D04657 |
Lacidipine (USAN/INN); Motens (TN) |
(P) unclassified |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04733 |
Lidoflazine (USAN/INN); Angex (TN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
| D04786 |
Loviride (USAN/INN) |
(P) unclassified |
| D04820 |
Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) |
(CI,P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04965 |
Perphenazine hydrochloride; Perphenazine dihydrochloride; PZC intramuscular injection (TN) |
(P) unclassified |
| D05024 |
Mibefradil dihydrochloride (USAN); Posicor (TN) |
(P) unclassified |
| D05177 |
Nitisinone (JAN/USAN/INN); Orfadin (TN) |
(P) CYP inhibition: CYP2C9 |
| D05339 |
Paliperidone (JAN/USP/INN); Invega (TN) |
(P) unclassified |
| D05340 |
Paliperidone palmitate (JAN/USAN); Xeplion (TN); Trevicta (TN); Invega sustenna (TN); Invega trinza (TN) |
(P) unclassified |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05442 |
Perhexiline maleate (USAN) |
(P) unclassified |
| D05462 |
Oxycodone hydrochloride hydrate (JP18) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05538 |
Mozenavir (INN) |
(P) unclassified |
| D05732 |
Rioprostil (USAN/INN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D06060 |
Teludipine hydrochloride (USAN) |
(P) unclassified |
| D06068 |
Temsirolimus (JAN/USAN/INN); Torisel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06074 |
Tenofovir (USAN); Tenofovir hydrate |
(P) unclassified |
| D06199 |
Trabectedin (JAN/USAN/INN); Yondelis (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06213 |
Treprostinil (JAN/USAN/INN); Remodulin (TN) |
(P) unclassified |
| D06272 |
Sorafenib tosylate (USAN); Sorafenib tosilate (JAN); Nexavar (TN) |
(P) unclassified |
| D06274 |
Tafluprost (JAN/USAN/INN); Zioptan (TN) |
(P) unclassified |
| D06363 |
Ziconotide (USAN/INN); Prialt (TN) |
(P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06478 |
Darunavir ethanolate (JAN); Prezista (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D06580 |
Dexelvucitabine (USAN/INN); Reverset (TN) |
(P) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 CYP2C9 |
| D06670 |
Maraviroc (JAN/INN); Selzentry (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06676 |
Raltegravir (INN); MK-0518 |
(P) unclassified |
| D06677 |
Elvitegravir (JAN/USAN); Vitekta (TN) |
(P) unclassified |
| D07057 |
Abacavir (INN) |
(P) unclassified |
| D07132 |
Buprenorphine (JAN/INN); Temgesic (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07133 |
Raltegravir potassium (JAN/USAN); Isentress (TN) |
(P) unclassified |
| D07185 |
Fendiline (INN) |
(P) unclassified |
| D07450 |
Amlodipine (USP/INN); Norvasc (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07471 |
Atazanavir (INN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D07474 |
Atorvastatin (INN); Lipitor (TN); Sortis (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07494 |
Barnidipine (INN); Vasexten (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07507 |
Zidovudine and lamivudine; Combivir (TN); Lamivudine zidovudine (TN) |
(P) unclassified |
| D07509 |
Benidipine (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07520 |
Bepridil (INN); Bepadin (TN) |
(P) Enzyme: CYP2C9 CYP3A4 / CYP induction: CYP2C9 CYP3A4 |
| D07545 |
Brovincamine (INN); Sarbromin (TN) |
(P) unclassified |
| D07569 |
Candesartan cilexetil and anmlodipine besylate (JP18); Unisia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 CYP3A4 |
| D07661 |
Cerivastatin (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07782 |
Delavirdine (INN) |
(P) unclassified |
| D07845 |
Diltiazem (INN); Surazem (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07886 |
Efonidipine (INN) |
(P) unclassified |
| D07943 |
Fendiline hydrochloride; Sensit (TN) |
(P) unclassified |
| D07971 |
Flunarizine (INN); Sibelium (TN) |
(P) unclassified |
| D07983 |
Fluvastatin (INN); Fluvas (TN) |
(P) Enzyme: CYP2C9 CYP3A4 / CYP inhibition: CYP2C9 / CYP induction: CYP2C9 CYP3A4 |
| D08009 |
Gallopamil (INN) |
(P) unclassified |
| D08065 |
Iloprost tromethamine; Iloprost trometamol; Ventavis (TN) |
(P) unclassified |
| D08095 |
Ivabradine hydrochloride (JAN/USAN); Ivabrandine hydrochloride; Corlanor (TN); Corlentor (TN); Coralan (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08111 |
Lercanidipine (INN); Lercanil (TN) |
(P) unclassified |
| D08155 |
Manidipine (INN); Manidipine 6300; Artedil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08217 |
Mibefradil (INN) |
(P) unclassified |
| D08259 |
Nelfinavir (INN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D08270 |
Nicardipine (INN); Cardene (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08340 |
Perhexiline (INN) |
(P) unclassified |
| D08410 |
Pravastatin (INN); Pravator (TN) |
(P) unclassified |
| D08479 |
Rifampicin sodium; Rifadine (TN) |
(P) CYP induction: CYP3A4 |
| D08488 |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08492 |
Rosuvastatin (INN); Creston (TN) |
(P) unclassified |
| D08514 |
Sildenafil (INN); Aphrodil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08556 |
Tacrolimus (INN); Prograf (TN) |
(CI) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) unclassified |
| D08591 |
Tiaprost (INN); Iliren [veterinary] (TN) |
(P) unclassified |
| D08605 |
Tipranavir (INN); Aptivus (TN) |
(P) unclassified |
| D08628 |
Treprostinil monosodium salt; Treprostinil sodium; Trepulmix (TN) |
(P) unclassified |
| D08661 |
Unoprostone (INN); Rescula (TN) |
(P) unclassified |
| D08667 |
Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
(P) unclassified |
| D08668 |
Vardenafil (USAN/INN); Levitra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D08686 |
Ziconotide acetate; Prialt (TN) |
(P) unclassified |
| D08768 |
Promethazine hibenzate; Hiberna (TN) |
(P) unclassified |
| D08775 |
Abacavir sulfate and lamivudine; Epzicom (TN) |
(P) unclassified |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08860 |
Apremilast (JAN/USAN); Otezla (TN) |
(P) unclassified |
| D08892 |
Clevidipine (USAN/INN); Clevidipine butyrate; Cleviprex (TN) |
(P) unclassified |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09017 |
Ticagrelor (JAN/USAN/INN); Brilinta (TN) |
(CI,P) unclassified |
| D09321 |
Obinutuzumab (USAN/INN); Obinutuzumab (genetical recombination) (JAN); Gazyva (TN) |
(P) unclassified |
| D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09572 |
Riociguat (JAN/USAN/INN); Adempas (TN) |
(P) unclassified |
| D09594 |
Olmesartan medoxomil and azelnidipine; Rezaltas (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09621 |
Gisadenafil (USAN/INN) |
(P) unclassified |
| D09622 |
Gisadenafil besylate (USAN) |
(P) unclassified |
| D09634 |
Lersivirine (USAN/INN) |
(P) unclassified |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09687 |
Ulipristal acetate (JAN/USAN); Ella (TN) |
(P) unclassified |
| D09701 |
Abiraterone acetate (JAN/USP); Zytiga (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09720 |
Rilpivirine (JAN/USAN/INN); Rekambys (TN) |
(P) unclassified |
| D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09730 |
Olaparib (JAN/USAN/INN); Lynparza (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09741 |
Drospirenone and ethinylestradiol; Drospirenone and ethinylestradiol betadex; Angeliq (TN); Yaz (TN); Flexyess (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09743 |
Telmisartan and amlodipine besilate (JP18); Telmisartan and amlodipine besylate; Micamlo (TN); Twynsta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09745 |
Valsartan and amlodipine besilate; Exforge (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09789 |
Kirenidipine hydrochloride (JAN) |
(P) unclassified |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
| D09873 |
Bedaquiline fumarate (JAN/USAN); Sirturo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(P) unclassified |
| D09906 |
Fosdevirine (USAN/INN) |
(P) unclassified |
| D09920 |
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN); Lenvima (TN) |
(P) unclassified |
| D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(P) unclassified |
| D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(P) unclassified |
| D09958 |
Rilpivirine hydrochloride (JAN/USAN); Edurant (TN) |
(P) unclassified |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09989 |
Vardenafil hydrochloride (USP) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP inhibition: CYP2C9 / CYP induction: CYP3A4 |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
| D10019 |
Panobinostat lactate (JAN); Farydak (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(P) Enzyme: CYP2C9 CYP3A4 / CYP induction: CYP2C9 CYP3A4 |
| D10027 |
Udenafil (USAN/INN) |
(P) unclassified |
| D10066 |
Dolutegravir (USAN); Tivicay (TN) |
(P) unclassified |
| D10082 |
Suvorexant (JAN/USAN); MK-4305; Belsomra (TN) |
(P) unclassified |
| D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 CYP2C9 |
| D10113 |
Dolutegravir sodium (JAN/USAN); Tivicay (TN) |
(P) unclassified |
| D10131 |
Ixazomib citrate (JAN/USAN); Ninlaro (TN) |
(P) unclassified |
| D10135 |
Macitentan (JAN/USAN); Opsumit (TN) |
(CI,P) Enzyme: CYP3A4 / Target: EDNRA EDNRB / CYP induction: CYP3A4 |
| D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(P) unclassified |
| D10243 |
Irbesartan and amlodipine besilate (JP18); Aimix (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10293 |
Carbidopa, levodopa and entacapone; Stalevo (TN) |
(P) CYP inhibition: CYP2C9 |
| D10298 |
Brimonidine tartrate and timolol maleate; Combigan (TN); Aibeta (TN) |
(P) unclassified |
| D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10428 |
Tenofovir alafenamide (USAN/INN) |
(P) unclassified |
| D10430 |
Treprostinil diolamine (USAN); Orenitram (TN) |
(P) unclassified |
| D10441 |
Latanoprostene bunod (USAN/INN); Vyzulta (TN) |
(P) unclassified |
| D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10452 |
Cabazitaxel acetonate (JAN); Cabazitaxel acetone; Jevtana (TN) |
(P) unclassified |
| D10461 |
Dienogest and estradiol valerate; Natazia (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10478 |
Naldemedine tosylate (JAN/USAN); Naldemedine tosilate; Symproic (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10480 |
Irbesartan and trichlormethiazide; Irtra (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10524 |
Azilsartan and amlodipine besilate; Zacras (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10548 |
Cabotegravir (JAN/USAN/INN); Vocabria (TN); Apretude (TN) |
(P) unclassified |
| D10549 |
Cabotegravir sodium (JAN/USAN); Vocabria (TN) |
(P) unclassified |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) CYP inhibition: CYP2C9 |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10568 |
Pitavastatin calcium hydrate (JP18); Livalo (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D10571 |
Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine; Complera (TN); Eviplera (TN) |
(P) unclassified |
| D10600 |
Dolutegravir, abacavir and lamivudine; Triumeq (TN) |
(P) unclassified |
| D10605 |
Tenofovir alafenamide fumarate (JAN/USAN); Vemlidy (TN) |
(P) unclassified |
| D10624 |
Doravirine (JAN/USAN/INN); Pifeltro (TN) |
(P) unclassified |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(P) unclassified |
| D10688 |
Abemaciclib (JAN/USAN/INN); Verzenio (TN) |
(P) unclassified |
| D10711 |
Pemafibrate (JAN); Parmodia (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D10753 |
Atazanavir and cobicistat; Evotaz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10754 |
Lamivudine and raltegravir; Lamivudine and raltegravir potassium; Dutrebis (TN) |
(P) unclassified |
| D10755 |
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide; Genvoya (TN) |
(P) unclassified |
| D10756 |
Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil; Stribild (TN) |
(P) unclassified |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10766 |
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10780 |
Perampanel hydrate (JAN); Fycompa (TN) |
(P) unclassified |
| D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) CYP induction: CYP2C9 |
| D10805 |
Telmisartan, amlodipine and hydrochlorothiazide; Micatrio (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10832 |
Darunavir and cobicistat; Prezcobix (TN); Rezolsta (TN) |
(P) unclassified |
| D10834 |
Tenofovir disoproxil phosphate |
(P) unclassified |
| D10835 |
Emtricitabine and tenofovir alafenamide; Descovy (TN) |
(P) unclassified |
| D10836 |
Emtricitabine, rilpivirine and tenofovir alafenamide; Odefsey (TN) |
(P) unclassified |
| D10838 |
Abacavir, lamivudine and zidovudine; Trizivir (TN) |
(P) unclassified |
| D10851 |
Efavirenz, emtricitabine and tenofovir disoproxil; Atripla (TN) |
(P) unclassified |
| D10854 |
Brinzolamide and brimonidine tartrate; Simbrinza (TN); Ailamide (TN) |
(P) unclassified |
| D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10892 |
Esaxerenone (JAN/INN) |
(P) unclassified |
| D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(P) unclassified |
| D10909 |
Bictegravir (USAN/INN) |
(P) unclassified |
| D10910 |
Bictegravir sodium (JAN/USAN) |
(P) unclassified |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11022 |
Lemborexant (JAN/USAN/INN); Dayvigo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11039 |
Bictegravir, emtricitabine and tenofovir alafenamide; Biktarvy (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11045 |
Darolutamide (JAN/USAN/INN); Nebeqa (TN) |
(P) unclassified |
| D11048 |
Upadacitinib hydrate (JAN); Upadacitinib hemihydrate; Rinvoq (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11070 |
Tirabrutinib hydrochloride (JAN/USAN); Velexbru (TN) |
(P) unclassified |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D11092 |
Pitavastatin magnesium; Zypitamag (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D11093 |
Avacopan (JAN/USAN/INN); Tavneos (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11095 |
Atorvastatin calcium propylene glycol solvate |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11190 |
Vosoritide (USAN/INN); Vosoritide (genetical recombination) (JAN); Voxzogo (TN) |
(P) unclassified |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11246 |
Dapivirine (USAN/INN) |
(P) unclassified |
| D11282 |
Dolutegravir sodium and rilpivirine hydrochloride; Juluca (TN) |
(P) unclassified |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11382 |
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide; Symtuza (TN) |
(P) unclassified |
| D11391 |
Tenofovir disoproxil maleate |
(P) unclassified |
| D11392 |
Efavirenz, lamivudine and tenofovir disoproxil fumarate; Symfi (TN) |
(P) unclassified |
| D11395 |
Lamivudine and tenofovir disoproxil; Cimduo (TN); Temixys (TN) |
(P) unclassified |
| D11396 |
Doravirine, lamivudine and tenofovir disoproxil; Delstrigo (TN) |
(P) unclassified |
| D11400 |
Abrocitinib (JAN/USAN); Cibinqo (TN) |
(P) Enzyme: CYP2C9 / CYP induction: CYP2C9 |
| D11404 |
Asciminib hydrochloride (JAN/USAN); Scemblix (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11521 |
Lamivudine, nevirapine and zidovudine |
(P) unclassified |
| D11522 |
Dolutegravir and lamivudine; Dovato (TN) |
(P) unclassified |
| D11659 |
Tolvaptan sodium phosphate (JAN); Samtasu (TN) |
(P) unclassified |
| D11662 |
Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) |
(P) unclassified |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(P) unclassified |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11881 |
Amlodipine benzoate; Katerzia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
| D12005 |
Treprostinil palmitil (USAN/INN) |
(P) unclassified |
| D12015 |
St. John's wort; SJW |
(P) unclassified |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12269 |
Nirmatrelvir and ritonavir; Paxlovid (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12311 |
Bortezomib hydrate (JAN) |
(P) unclassified |
| D12353 |
Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN); Xocova (TN) |
(P) unclassified |
| D12437 |
Ripasudil hydrochloride and brimonidine tartrate; Gla-alpha (TN) |
(P) unclassified |
| D12494 |
Foslevodopa and foscarbidopa; Vyalev (TN) |
(P) unclassified |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(CI,P) unclassified |
| D12599 |
Bimatoprost grenod (USAN) |
(P) unclassified |
| D12617 |
Sepetaprost (JAN/INN) |
(P) unclassified |
| D12629 |
Treprostinil phosphate (USAN); Treprostinil biphosphate |
(P) unclassified |
| D12637 |
Darunavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D12752 |
Darunavir propylene glycolate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
